267 related articles for article (PubMed ID: 18190288)
21. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
Dhawan D; Mayer KH
J Infect Dis; 2006 Jan; 193(1):36-44. PubMed ID: 16323129
[TBL] [Abstract][Full Text] [Related]
22. Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?
Bollen LJ; Whitehead SJ; Mock PA; Leelawiwat W; Asavapiriyanont S; Chalermchockchareonkit A; Vanprapar N; Chotpitayasunondh T; McNicholl JM; Tappero JW; Shaffer N; Chuachoowong R
AIDS; 2008 Jun; 22(10):1169-76. PubMed ID: 18525263
[TBL] [Abstract][Full Text] [Related]
23. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections.
Nikolic DS; Garcia E; Piguet V
Expert Rev Anti Infect Ther; 2007 Feb; 5(1):77-88. PubMed ID: 17266456
[TBL] [Abstract][Full Text] [Related]
24. Mothers' attitudes towards using services preventing mother-to-child HIV/AIDS transmission in Zimbabwe: an interview survey.
Chivonivoni C; Ehlers VJ; Roos JH
Int J Nurs Stud; 2008 Nov; 45(11):1618-24. PubMed ID: 18502426
[TBL] [Abstract][Full Text] [Related]
25. Current issues in prevention of mother-to-child transmission of HIV-1.
Coovadia H
Curr Opin HIV AIDS; 2009 Jul; 4(4):319-24. PubMed ID: 19532071
[TBL] [Abstract][Full Text] [Related]
26. Fourth International Congress on AIDS in Asia and the Pacific.
Phanuphak P
J Int Assoc Physicians AIDS Care; 1998 Feb; 4(2):22-5. PubMed ID: 11365085
[TBL] [Abstract][Full Text] [Related]
27. Co-occurrence of treatment nonadherence and continued HIV transmission risk behaviors: implications for positive prevention interventions.
Kalichman SC
Psychosom Med; 2008 Jun; 70(5):593-7. PubMed ID: 18519882
[TBL] [Abstract][Full Text] [Related]
28. Vaginal microbicides.
O'Brien RF
Adolesc Med Clin; 2006 Oct; 17(3):673-85; abstract xi. PubMed ID: 17030285
[TBL] [Abstract][Full Text] [Related]
29. Retrovirus meeting. Back-to-basics push as HIV prevention struggles.
Cohen J
Science; 2008 Feb; 319(5865):888. PubMed ID: 18276859
[No Abstract] [Full Text] [Related]
30. [Treatment of HIV-infected pregnant women: prevention of virus transmission and adverse effects in mother and child].
Boer K; Nellen JF; Kreyenbroek ME; Godfried MH
Ned Tijdschr Geneeskd; 2009; 153():B410. PubMed ID: 19785876
[TBL] [Abstract][Full Text] [Related]
31. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW
Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656
[TBL] [Abstract][Full Text] [Related]
32. Topical microbicides for disease prevention: status and challenges.
Harrison PF; Rosenberg Z; Bowcut J
Clin Infect Dis; 2003 May; 36(10):1290-4. PubMed ID: 12746775
[TBL] [Abstract][Full Text] [Related]
33. IL-10-secreting T cells from HIV-infected pregnant women downregulate HIV-1 replication: effect enhanced by antiretroviral treatment.
Bento CA; Hygino J; Andrade RM; Saramago CS; Silva RG; Silva AA; Linhares UC; Brindeiro R; Tanuri A; Rosenzwajg M; Klatzmann D; Andrade AF
AIDS; 2009 Jan; 23(1):9-18. PubMed ID: 19050381
[TBL] [Abstract][Full Text] [Related]
34. Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection.
Supapol WB; Remis RS; Raboud J; Millson M; Tappero J; Kaul R; Kulkarni P; McConnell MS; Mock PA; Culnane M; McNicholl J; Roongpisuthipong A; Chotpitayasunondh T; Shaffer N; Butera S
J Infect Dis; 2008 May; 197(10):1369-77. PubMed ID: 18419578
[TBL] [Abstract][Full Text] [Related]
35. [HIV infection in women in childbearing age].
Olczak A; Grabczewska E; Fórmaniak J
Przegl Epidemiol; 2008; 62(4):785-92. PubMed ID: 19209741
[TBL] [Abstract][Full Text] [Related]
36. Resistance to antiretrovirals in HIV-infected pregnant women.
Weinberg A; Forster-Harwood J; McFarland EJ; Pappas J; Davies JK; Kinzie K; Barr EA; Paul SM; Salbenblatt CR; Soda E; Vazquez A; Levin MJ
J Clin Virol; 2009 May; 45(1):39-42. PubMed ID: 19329355
[TBL] [Abstract][Full Text] [Related]
37. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
[TBL] [Abstract][Full Text] [Related]
38. [Pathogenesis of HIV infection as the key to eradication? New therapeutic approaches].
Manegold C
MMW Fortschr Med; 2000 Mar; 142 Suppl 1():34-9. PubMed ID: 10863308
[TBL] [Abstract][Full Text] [Related]
39. Pregnancy and optimal care of HIV-infected patients.
Anderson BL; Cu-Uvin S
Clin Infect Dis; 2009 Feb; 48(4):449-55. PubMed ID: 19133799
[TBL] [Abstract][Full Text] [Related]
40. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.
American Academy of Pediatrics Committee on Pediatric AIDS
Pediatrics; 2008 Nov; 122(5):1127-34. PubMed ID: 18977995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
